Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA TM*) in Multiple Sclerosis Sanofi, 11 Nov 2011 Accessed on 7 Dec 2011 from http://en.sanofi.com/Images/29137_20111114_CARE_en.pdf. CommentRecommendBookmarkWatch